RPID Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

11.20M

+36.29%

-0.230

+4.55%

8.90M

+23.53%

-0.210

-19.23%

9.40M

+29.44%

-0.200

-25.93%

Estimates Revision

The market is revising Upward the revenue expectations for Rapid Micro Biosystems, Inc. (RPID) for FY2025, with the revenue forecasts being adjusted by 4.44% over the past three months. During the same period, the stock price has changed by -9.61%.

Revenue Estimates for FY2025

Revise Upward

+4.44%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+0.17%

In Past 3 Month

Stock Price

Go Down

-9.61%

In Past 3 Month

3 Analyst Rating

Wall Street analysts forecast RPID stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RPID is 8.00 USD with a low forecast of 8.00 USD and a high forecast of 8.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

0 Hold

0 Sell

Strong Buy

Current: 0.000

Low

8.00

Averages

8.00

High

8.00

Current: 0.000

Low

8.00

Averages

8.00

High

8.00

Lake Street

NULL -> Buy

initiated

2025-07-28

Reason

Lake Street

Price Target

2025-07-28

initiated

NULL -> Buy

Reason

Lake Street initiated coverage of Rapid Micro Biosystems with a Buy rating and $8 price target. Rapid is \"emerging as the category leader\" in microbial quality control automation with its Growth Direct platform, says the analyst, who believes the market has yet to fully appreciate the already existing scale and growing adoption of Growth Direct. The firm sees further upside as recurring revenue continues to scale given \"the stickiness of the platform,\" the analyst added.

Keybanc

Paul Knight

Buy

Initiates

2025-02-12

Reason

Keybanc

Paul Knight

Price Target

2025-02-12

Initiates

Buy

Reason

KeyBanc initiated coverage of Rapid Micro Biosystems with an Overweight rating and $8 price target. The analyst believes Rapid Micro's Microbial Growth Direct System is "changing the paradigm" in biological manufacturing quality control. The system is more accurate and provides digital results in three to five days versus manual methods in 5-14 days, the analyst tells investors in a research note. KeyBanc says Rapid Micro is gaining wide adoption in the biopharmaceutical industry that will increase sales visibility and improve margins.

Valuation Metrics

The current forward P/E ratio for Rapid Micro Biosystems Inc (RPID.O) is -3.69, compared to its 5-year average forward P/E of -3.33. For a more detailed relative valuation and DCF analysis to assess Rapid Micro Biosystems Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-3.33

Current PE

-3.69

Overvalued PE

0.55

Undervalued PE

-7.22

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-2.02

Current EV/EBITDA

-2.68

Overvalued EV/EBITDA

3.73

Undervalued EV/EBITDA

-7.77

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

6.31

Current PS

3.51

Overvalued PS

14.31

Undervalued PS

-1.70

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

RPID News & Events

Events Timeline

No data

News

9.5

2025-11-08Yahoo Finance

Highlights from Rapid Micro Biosystems Inc (RPID) Q3 2025 Earnings Call: Record Revenue Achieved

9.5

2025-11-07NASDAQ.COM

RAPID MICRO BIOSYSTEMS, INC. Reports Q3 Loss Below Expectations

1.0

2025-10-30Newsfilter

Rapid Micro Biosystems to Attend the Stifel 2025 Healthcare Conference

People Also Watch

Frequently Asked Questions

What is Rapid Micro Biosystems Inc (RPID) stock price today?

The current price of RPID is 3.245 USD — it has increased 0 % in the last trading day.

What is Rapid Micro Biosystems Inc (RPID)'s business?

Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.

What is the price predicton of RPID Stock?

What is Rapid Micro Biosystems Inc (RPID)'s revenue for the last quarter?

Rapid Micro Biosystems Inc revenue for the last quarter amounts to 7.84M USD, increased 3.08 % YoY.

What is Rapid Micro Biosystems Inc (RPID)'s earnings per share (EPS) for the last quarter?

Rapid Micro Biosystems Inc. EPS for the last quarter amounts to -0.26 USD, decreased -0.00 % YoY.

What changes have occurred in the market's expectations for Rapid Micro Biosystems Inc (RPID)'s fundamentals?

How many employees does Rapid Micro Biosystems Inc (RPID). have?

Rapid Micro Biosystems Inc (RPID) has 163 emplpoyees as of January 09 2026.

What is Rapid Micro Biosystems Inc (RPID) market cap?

Today RPID has the market capitalization of 143.83M USD.